Bill

Bill > A09045


NY A09045

NY A09045
Ensures reimbursement practices of pharmacy benefit managers do not allow for reimbursement of an amount less than the cost of procuring the drugs.


summary

Introduced
09/05/2025
In Committee
01/07/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the public health law, in relation to reimbursement rates of pharmacy benefit managers

AI Summary

This bill amends the New York public health law to regulate pharmacy benefit managers (PBMs), which are intermediaries that manage prescription drug benefits for health insurance plans. The bill requires PBMs to ensure that pharmacies are reimbursed fairly by establishing two key provisions: first, if a pharmacy challenges a reimbursement rate and an appeal is denied, the PBM must identify a therapeutically equivalent drug that can be purchased at or below the maximum allowable cost, and if no such drug is available, the PBM must adjust its pricing methodology and allow the pharmacy to reverse and rebill claims; second, PBMs are prohibited from reimbursing a pharmacy or pharmacist an amount less than what they would reimburse their own affiliated pharmacies for the same services, with reimbursement calculated on a per-unit basis using the same generic product identifier. The goal of this legislation is to prevent PBMs from engaging in practices that could potentially underpay pharmacies and create financial challenges for local drug stores. The bill will take effect 90 days after becoming law.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

referred to health (on 01/07/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...